In this episode of JAMA+ AI Conversations, Roy Perlis, MD, MSc, and Joseph Geraci, PhD, of Queen's University discuss using machine learning to analyze clinical trials and related FDA interactions. Geraci's work focuses on identifying subpopulations with different responses to help plan and analyze future trials. Related Content: Enriching Clinical Trials With Machine Learning
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from JAMA+ AI Conversations
From Aging to AI and Beyond: A Conversation With Eric Topol
ADVOCATing for Patients With Heart Failure
From the JAMA Network: Acoustic Analysis of Primary Care Patient–Clinician Conversations to Screen for Cognitive Impairment
From the JAMA Network: AI Scribes Are Here, but Is Health Care Ready?
Get summaries like this every morning.
Free AI-powered recaps of JAMA+ AI Conversations and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.